Risk factors
4D Molecular Therapeutics (FDMT) risk factors
Item 1A of every 4D Molecular Therapeutics, Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
85 risks. Late-stage gene-therapy development remains unproven, with no approved products or product revenue.
Filed Mar 18, 2026